Bone marrow transplantation for β-thalassemia: the university of california san francisco experience

American Journal of Pediatric Hematology/Oncology

Volumn 22, Issue 6, 2000, Pages 598-601

  Mentzer, William C ^a   Cowan, Morton J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bone marrow transplantation; Key Words; Thalassemia

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ALLOTRANSPLANTATION; ARTICLE; ASIA; BETA THALASSEMIA; BONE MARROW TRANSPLANTATION; CHILD; DISEASE FREE SURVIVAL; ETHNOLOGY; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; METHODOLOGY; MIDDLE EAST; MORTALITY; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SURVIVAL RATE; UNITED STATES; UNIVERSITY HOSPITAL;

ADOLESCENT; ASIA; BETA-THALASSEMIA; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; GRAFT REJECTION; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITALS, UNIVERSITY; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; INFANT; MIDDLE EAST; RETROSPECTIVE STUDIES; SAN FRANCISCO; SURVIVAL RATE; TRANSPLANTATION, HOMOLOGOUS;

EID: 0034323119     PISSN: 01928562     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200011000-00030     Document Type: Article

References (28)

1. Thomas ED, Buckner CD, Sanders JE, et al. Marrow transplantation for thalassemia. Lancet 1982;ii:227-29.
2. Giardini C. Treatment of beta-thalassemia. Curr Opin Hematol 1997; 4:79-87.
3. Lucarelli G, Galimberti M, Polchi P, et al. Bone marrow transplantation in patients with thalassemia. N Engl J Med 1990; 322:417-21.
4. Lucarelli G, Giardini C, Baronciani D. Bone marrow transplantation in beta-thalassemia. Semin Hematol 1995; 32:297-303.
5. Lucarelli G. Bone marrow transplantation for thalassaemia. J Intern Med 1997; 740(S):49-52.
6. Clift RA, Johnson FL. Marrow transplants for thalassemia. The USA experience. Bone Marrow Transplant 1997; 19(S2):57-9.
7. Issaragrisil S, Visudhisakchai S, Suvatte V, et al. Bone marrow transplantation for thalassemia in Thailand. Bone Marrow Transplant 1993; 12(S1):42-4.
8. Issaragrisil S, Visuthisakchai S, Suvatte V, et al. Transplantation of cord blood stem cells into a patient with severe thalassemia. N Engl J Med 1995; 332:367-9.
9. Galimberti M, Lucarelli G, Polchi P, et al. HLA-mismatched bone marrow transplantation in thalassemia. Bone Marrow Transplant 1991; 7(S7):98-100.
10. Sullivan KM, Anasetti C, Horowitz M, et al. Unrelated and HLA-Nonidentical related donor marrow transplantation for thalassemia and leukemia. Ann NY Acad Sci 1998; 850:312-24.
11. Contu L, La Nasa G, Arras M, et al. Successful unrelated bone marrow transplantation in beta-thalassemia. Bone Marrow Transplant 1994; 13:329-31.
12. Kelly P, Kurtzberg J, Vichinsky E, et al. Umbilical cord blood stem cells: Application for the treatment of patients with hemoglobinopathies. J Pediatr 1997; 130:695-703.
13. Miniero F, Rocha V, Saracco P, et al. Cord blood transplantation (CBT) in hemoglobinopathies. Bone Marrow Transplant 1998; 22(S1):S78-9.
14. Harris RE, Joiner CH. Should children with hemoglobinopathies be offered unrelated-donor cord blood stem cell transplantation? J Pediatr 1997; 130:689-91.
15. Werner E, Yanovich S, Rubinstein P, et al. Unrelated placental cord blood transplantation in a patient with sickle cell disease and acute non-lymphocytic leukemia. Blood 1997; 90(SI):399b.
16. Storb R, Yu C, Deeg HJ, et al. Current and future preparative regimens for bone marrow transplantation in thalassemia. Ann NY Acad Sci 1998; 850:276-87.
17. Piga A, Longo F, Voi V, et al. Late effects of bone marrow transplantation for thalassemia. Ann NY Acad Sci 1998; 850:294-9.
18. Socie G, Stone JV, Wingard JR, et al. Long-term survival and late deaths after allogeneic bone marrow transplantation. N Engl J Med 1999; 341:14-21.
19. Thomas ED. Does bone marrow transplantation confer a normal life span? N Engl J Med 1999; 341:50-1.
20. Westgren M, Ringden O, Eik-Nes S, et al. Lack of evidence of permanent engraftment after in utero fetal stem cell transplantation in congenital hemoglobinopathies. Transplantation 1996; 61:1176-9.
21. Touraine JL. Rationale and results of in utero transplants of stem cells in humans. Bone Marrow Transplant 1992; 8:121-6.
22. Andreani M, Manna M, Lucarelli G, et al. Persistence of mixed chimerism in patients transplanted for the treatment of thalassemia. Blood 1996; 87:3494-9.
23. Kapelushnik J, Or R, Filon D, et al. Analysis of beta-globin mutations shows stable mixed chimerism in patients with thalassemia after bone marrow transplantation. Blood 1995; 86:3241-6.
24. Slavin S, Nagler A, Naparstek E, et al. Non myeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 1998; 91:756-63.
25. Storb R, Yu C, Wagner JL, et al. Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation. Blood 1997; 89:3048-54.
26. Yu C, Nash R, Lothrop C, et al. Severe canine hereditary hemolytic anemia treated by marrow grafts using nonmyeloablative immunosuppression. Blood 1998; 92(S1):263A.
27. Niederwieser D, McSweeney P, Blume K, et al. Induction of complete or mixed chimerism using minimal conditioning and related or unrelated stem cell donors in patients with myeloid malignancies. Ann Hematol 1999; 78(S2):S19.
28. Storb R, Yu C, Barnett T, et al. Stable mixed hematopoietic chimerism in dog leukocyte antigen-identical littermate dogs given lymph node irradiation before and pharmacologic immunosuppression after marrow transplantation. Blood 1999; 94:1131-6.